The Current Ratio as of December 2025 (TTM) for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is 3.50

According to Chengdu Easton Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 3.50. This represents a change of 3.18% compared to the average of 3.39 of the last 4 quarters.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Historical Current Ratio (quarterly & annually)

How has 688513.SS Current Ratio performed in the past?

The mean historical Current Ratio of Chengdu Easton Biopharmaceuticals Co., Ltd. over the last ten years is 3.21. The current 3.50 Current Ratio has changed 10.79% with respect to the historical average. Over the past ten years (40 quarters), 688513.SS's Current Ratio was at its highest in in the September 2020 quarter at 5.36. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chengdu Easton Biopharmaceuticals Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Average Current Ratio

How has 688513.SS Current Ratio performed in the past?

The current Current Ratio of Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Current Ratio vs. Peers

How is 688513.SS’s Current Ratio compared to its peers?

Chengdu Easton Biopharmaceuticals Co., Ltd.’s Current Ratio is less than Shanghai Haohai Biological Technology Co., Ltd. (3.77), less than Chengdu Kanghua Biological Products Co., Ltd. (5.85), less than Aurisco Pharmaceutical Co.,Ltd. (4.30), greater than Anhui Huaheng Biotechnology Co., Ltd. (1.44), greater than Zhejiang Ausun Pharmaceutical Co., Ltd. (2.84), greater than Zhejiang Jolly Pharmaceutical Co.,LTD (1.86), greater than Chengzhi Shareholding Co., Ltd. (1.46), greater than Chengdu Olymvax Biopharmaceuticals Inc. (1.52), less than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (5.57), greater than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (0.98),

Build a custom stock screener for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chengdu Easton Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chengdu Easton Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.